Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, γδ T cells, and antigen- specific CTL

Journal of Immunology

Volumn 160, Issue 11, 1998, Pages 5239-5245

  Bakker, Alexander B H ^a   Phillips, Joseph H ^a   Figdor, Carl G ^b   Lanier, Lewis L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; MELANOMA; NATURAL KILLER CELL; PRIORITY JOURNAL;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; MELANOMA; MICE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032101973     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Ruiter, D. J., V. Mattijssen, E. B. Broecker, and S. Ferrone. 1991. MHResC antigens in human melanomas. Semin. Cancer Biol. 2:35.
2. Cordon-Cardo, C., Z. Fuks, M. Drobnjak, C. Moreno, L. Eisenbach, and M. Feldman. 1991. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res. 51:6372.
3. Lehmann, F., M. Marchand, P. Hainaut, P. Pouillart, X. Sastre, H. Ikeda, T. Boon, and P. G. Coulie. 1995. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 25:340.
4. Karre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319:675.
5. Storkus, W. J., J. Alexander, J. A. Payne, J. R. Dawson, and P. Cresswell. 1989. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc. Natl. Acad. Sci. USA 86:2361.
6. Shimizu, Y., and R. DeMars. 1989. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression. Eur. J. Immunol. 19:447.
7. Wagtmann, N., R. Biassoni, C. Cantoni, S. Verdiani, M. S. Malnati, M. Vitale, C. Bottino, L. Moretta, A. Moretta, and E. O. Long. 1995. Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intracellular domains. Immunity 2:439.
8. Colonna, M., and J. Samaridis. 1995. Cloning of Ig-superfamily members associated with HLA-C and HLA-B recognition by human NK cells. Science 268: 405.
9. D'Andrea, A., C. Chang, K. Franz-Bacon, T. McClanahan, J. H. Phillips, and L. L. Lanier. 1995. Molecular cloning of NKB1: a natural killer cell receptor for HLA-B allotypes. J. Immunol. 155:2306.
10. Lanier, L. L. 1997. NK cells: from no receptors to too many. Immunity 6:371.
11. Moretta, A., M. Vitale, C. Bottino, A. M. Orengo, L. Morelli, R. Augugliaro. M. Barbaresi, E. Ciccone, and L. Moretta. 1993. p58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells: anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 178:597.
12. Litwin, V., J. Gumperz, P. Parham, J. H. Phillips, and L. L. Lanier. 1994. NKB1: an NK cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180:537.
13. Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J.-P. Kinet, and E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4:77.
14. Fry, A., L. L. Lanier, and A. Weiss. 1996. Phosphotyrosines in the KIR motif of NKB1 are required for negative signaling and for association with PTP1C. J. Exp. Med. 184:295.
15. Philips, J. H., C. Chang, J. Mattson, J. E. Gumperz, P. Parham, and L. L. Lanier. 1996. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, -B, and -C allotypes. Immunity 5:163.
16. Lazetic, S., C. Chang, J. P. Houchins, L. L. Lanier, and J. H. Phillips. 1996. Human NK cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 157:4741.
17. Soderstrom, K., B. Corliss, L. L. Lanier, and J. H. Phillips. 1997. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J. Immunol. 159:1072.
18. Lanier, L. L., B. Corliss, and J. H. Phillips. 1997. Arousal and inhibition of human NK cells. Immunol. Rev. 155:145.
19. Litwin, V., J. Gumperz, P. Parham. J. H. Phillips, and L. L. Lanier. 1993. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J. Exp. Med. 178:1321.
20. Kawakami, Y., R. Zakut, S. L. Topalian, H. Stotter, and S. A. Rosenberg. 1992. Shared human melanoma antigens: recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J. Immunol. 148:638.
21. D'Urso, C. M., Z. G. Wang, Y. Cao, R. Tatake, R. A. Zeff, and S. Ferrone. 1991. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in β2 m gene expression. J. Clin. Invest. 87:284.
22. Bakker, A. B. H., M. W. J. Schreurs, A. J. de Boer, Y. Kawakami, S. A. Rosenberg, G. J. Adema, and C. G. Figdor. 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179:1005.
23. Wagtmann, N., S. Rajagopalan, C. C. Winter, M. Peruzzi, and E. O. Long. 1995. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3:801.
24. Roland, J., and P.-A. Cazenave. 1992. Ly-49 antigen defines an αβ TCR population in i-IEL with an extrathymic maturation. Int. Immunol. 4:699.
25. Gumperz, J. E., J. C. M. Patterson, V. Litwin, N. Valiante, L. L. Lanier, P. Parham, and A.-M. Little. 1996. Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor. Tissue Antigens 48:278.
26. Phillips, J. H., J. E. Gumperz, P. Parham, and L. L. Lanier. 1995. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268:403.
27. Gumperz, J. E., V. Litwin, J. H. Phillips, L. L. Lanier, and P. Parham. 1995. The Bw4 public epitope of HLA-B molecules confers reactivity with NK cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181:1133.
28. Colonna, M., G. Borsellino, M. Falco, G. B. Ferrara, and J. L. Strominger. 1993. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. USA 90:12000.
29. Marincola, F. M., P. Shamamian, R. B. Alexander, J. R. Gnarra, R. L. Turetskaya, S. A. Nedospasov, T. B. Simonis, J. K. Taubenberger, J. Yannelli, A. Mixon, N. P. Restifo, M. Herlyn, and S. H. Rosenberg. 1994. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J. Immunol. 153:1225.
30. Borst, J., R. J. van de Griend, J. W. van Oostveen, S. L. Ang, C. J. Melief, J. G. Seidman, and R. L. Bolhuis. 1987. A T-cell receptor gamma/CD3 complex found on cloned functional lymphocytes. Nature 325:683.
31. Lanier, L. L., J. Gumperz, P. Parham, I. Melero, M. Lopez-Botet, and J. H. Phillips. 1995. The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J. Immunol. 154:3320.
32. Poccia, F., B. Cipriani, S. Vendetti, V. Colizzi, Y. Poquet, L. Battistini, M. Lopez-Botet, J-J. Fournié, and M-L. Gougeon. 1997. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V-γ9Vδ2 T lymphocytes. J. Immunol. 159:6009.
33. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M-L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273.
34. Collona, M., F. Navarro, T. Bellón, M. Llano, P. García, J. Samaridis, L. Augman, M. Cella, and M. Lopez-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186:1809.
35. Stam, N. J., W. M. Kast, A. C. Voordouw, L. B. Pastoors, F. A. van der Hoven, C. J. M. Melief, and H. L. Ploegh. 1989. Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells. J. Immunol. 142:4113.
36. Pena, J., C. Alonso, R. Solana, R. Serrano, J. Carracedo, and R. Ramirez. 1990. Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors. Eur. J. Immunol. 20:2445.
37. 2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy. Proc. Natl. Acad. Sci. USA 94:13140.
38. Fan, Q. R., D. N. Garboczi, C. C. Winter, N. Wagtmann, E. O. Long, and D. C. Wiley. 1996. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc. Natl. Acad. Sci. USA 93:7178.
39. Leiden, J. M., B. A. Karpinski, L. Gottschalk, and J. Kornbluth. 1989. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class 1 HLA expression. J. Immunol. 142:2140.
40. Routes, J. M. 1992. IFN increases class I MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing. J. Immunol. 149:2372.
41. Gumperz, J. E., N. M. Valiante, P. Parham, L. L. Lanier, and D. Tyan. 1996. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different HLA types appear genetically regulated, but not linked to MHC haplotype. J. Exp. Med. 183:1817.
42. Valiante, N. M., K. Lienert, H. G. Shilling, B. J. Smits, and P. Parham. 1997. Killer cell receptors: keeping pace with MHC class I evolution. Immunol. Rev. 155:155.
43. Restifo, A. U. E. F., Y. Kawakami, J. W. Yewdell, J. J. Mule, S. A. Rosenberg, and J. R. Bennink. 1993. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177:265.
44. Cromme, F. V., J. Airey, M. T. Heemels, H. L. Ploegh, P. J. Keating, P. L. Stern, C. J. Meijer, and J. M. Walboomers. 1994. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. Exp. Med. 179:335.
45. Versteeg, R., K. M. Kruse-Wolters, A. C. Plomp, A. van Leeuwen, N. J. Stam, H. L. Ploegh, D. J. Ruiter, and P. I. Schrier. 1989. Suppression of class I human histocompatibility Jeukocyte antigen by c-myc is locus specific. J. Exp. Med. 170:621.
46. Kaufman, D. S., R. A. Schoon, and P. J. Leibson. 1992. Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells. Proc. Natl. Acad. Sci. USA 89:8337.
47. Malnati, M. S., P. Lusso, E. Ciccone, A. Moretta, L. Moretta, and E. O. Long. 1993. Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements. J. Exp. Med. 178:961.
48. Ferrini, S., A. Cambiaggi, R. Meazza, S. Sforzini, S. Marciano, M. C. Mingari, and L. Moretta. 1994. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 24:2294.
49. Mingari, M. C., C. Vitale, A. Cambiaggi, F. Schiavetti, G. Melioli, S. Ferrini, and A. Poggi. 1995. Cytotoxic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis of lymphokine production. Int. Immunol. 7:697.
50. Ikeda, H., B. Lethé, F. Lehmann, N. Van Baren, J.-F. Baurain, C. De Smet, H. Chambost, M. Vitale, A. Moretta, T. Boon, and P. G. Coulie. 1997. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6:199.
51. Leach, D. R., M. F. Krummel, and J. P. Allison. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734.
52. Valiante, N. M., M. Uhrberg, H. G. Shilling, K. Lienen-Weidenbach, K. L. Arnett, A. D'Andrea, J. H. Phillips, L. L. Lanier, and P. Parham. 1997. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two humans. Immunity 7:739.
53. M. Uhrberg, N. M. Valiante, B. P. Shum, H. G. Shilling, K. Lienert-Weidenbach, B. Corliss, D. Tyan, L. L. Lanier, and P. Parham. 1997. Human diversity in killer cell inhibitory receptor (KIR) genes. Immunity 7:753.
54. Braud, V., D. S. J. Allan, C. A. O'Callaghan, K. Soderstrom, A. D'Andrea, G. S. Ogg, S. Layetic, N. T. Young, J. I. Bell, J. H. Phillips, L. L. Lanier, and A. J. McMichael. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2 A, B, and C. Nature 391:795.